Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies
Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies
NCT ID: NCT03751644 Phase: NA Status: COMPLETED Enrollment: 6 Completion: 2021-04-29
Conditions
Electrical Remodeling, Rheumatic Diseases, Myopathy
Interventions
Electrical stimulation
Summary
Systemic autoimmune myopathies are a heterogeneous group of rheumatic diseases with progressive skeletal muscle weakness. The relevance of the peripherical neuromuscular electrical stimulation has never applied in the patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, investigator-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of an acute peripherical neuromuscular electrical stimulation session in patients with systemic autoimmune myopathies.
Primary Outcome
Frequency of treatment-emergent adverse events [safety and tolerability]